Projects per year
Personal profile
Education
- 2002 PhD, Department of Physiology, University of Oxford
Experience
- 1998~Present Attending Physician, Department of Obstetrics and Gynecology, National Cheng Kung University Hospital
- 2011~2012 Elected Visiting Fellow, Corpus Christi College, Oxford, United Kingdom
- 2011~Present Distinguished Professor, Departments of Pharmacology, Obstetrics and Gynecology, College of Medicine, National Cheng Kung University
- 2013~2019 Associate Dean, College of Medicine, National Cheng Kung University
- 2014~2017 Chairman, Department of Pharmacology, National Cheng Kung University
- 2015~2016 Discipline Coordinator, Pharmacology, Toxicology, Medicinal Biochemistry & Molecular Biology, Ministry of Science and Technology
- 2016~2019 Deputy Superintendent, National Cheng Kung University Hospital
- 2019/08~Present Superintendent, National Cheng Kung University Hospital
Research Interests
- Genomic medicine
- Drug development
- Molecular biology
- Cellular physiology
Fingerprint
Dive into the research topics where Meng-Ru Shen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 7 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects
Research Output
-
Application of an Artificial Intelligence Trilogy to Accelerate Processing of Suspected Patients with SARS-CoV-2 at a Smart Quarantine Station: Observational Study
Liu, P. Y., Tsai, Y. S., Chen, P. L., Tsai, H. P., Hsu, L. W., Wang, C. S., Lee, N. Y., Huang, M. S., Wu, Y. C., Ko, W. C., Yang, Y. C., Chiang, J. H. & Shen, M. R., 2020 Oct, In: Journal of medical Internet research. 22, 10, e19878.Research output: Contribution to journal › Article › peer-review
Open Access -
A Simplified Diagnostic Classification Scheme of Chemotherapy-Induced Peripheral Neuropathy
Huang, H. W., Wu, P. Y., Su, P. F., Li, C. I., Yeh, Y. M., Lin, P. C., Hsu, K. F., Shen, M. R., Chang, J. Y. & Lin, C. C. K., 2020, In: Disease Markers. 2020, 3402108.Research output: Contribution to journal › Article › peer-review
Open Access -
Author Correction: Germline susceptibility variants impact clinical outcome and therapeutic strategies for stage III colorectal cancer (Scientific Reports, (2019), 9, 1, (3931), 10.1038/s41598-019-40571-0)
Lin, P. C., Yeh, Y. M., Wu, P. Y., Hsu, K. F., Chang, J. Y. & Shen, M. R., 2020 Dec 1, In: Scientific reports. 10, 1, 12216.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Intratumor Heterogeneity of MYO18A and FBXW7 Variants Impact the Clinical Outcome of Stage III Colorectal Cancer
Lin, P. C., Yeh, Y. M., Lin, B. W., Lin, S. C., Chan, R. H., Chen, P. C. & Shen, M. R., 2020 Oct 29, In: Frontiers in Oncology. 10, 588557.Research output: Contribution to journal › Article › peer-review
Open Access -
Real-World Study of Adding Bevacizumab to Chemotherapy for Ovarian, Tubal, and Peritoneal Cancer as Front-Line or Relapse Therapy (ROBOT): 8-Year Experience
Wu, P. Y., Cheng, Y. M., Shen, M. R., Chen, Y. C., Huang, Y. F. & Chou, C. Y., 2020 Jul 14, In: Frontiers in Oncology. 10, 1095.Research output: Contribution to journal › Article › peer-review
Open Access